Vaccinations of U.S. children declined after publication of a now-refuted autism risk: study

By Judy Ashton
Vaccinations of U.S. children declined after publication of a now-refuted autism risk
UC researcher Lenisa Chang

(Medical Xpress) -- New University of Cincinnati research has found that fewer parents in the United States vaccinated their children in the wake of concerns about a purported link (now widely discredited) between the MMR (measles, mumps, rubella) vaccine and autism.
 
Lenisa Chang, assistant professor of economics in UC’s Carl H. Lindner College of Business, found that the MMR-autism controversy, which played out prominently in the popular media following publication in a 1998 medical journal, led to a decline of about two percentage points in terms of parents obtaining the MMR vaccine for their children in 1999 and 2000. And even after later studies thoroughly refuted the alleged MMR-autism link, the drop off in vaccination rates persisted.

For her study, “The MMR-Autism Controversy: Did Concerns Affect Vaccine Take Up?” to be presented during the 4th Biennial Conference of the American Society of Health Economics June 10-13 in Minnesota, Chang examined data from the National Immunization Survey from 1995 through 2006 to gauge ’ response toward the vaccine-autism controversy.
 
Interestingly, in the aftermath of the controversy, Chang found that the higher a mother’s education level, the less likely a child was to receive an MMR vaccination. In other words, college-educated mothers were less likely to have their children vaccinated than were non-college education mothers. This may be due to the fact that more educated mothers have better access and/or more quickly absorb medical information available in the media.

After epidemiological studies refuted the MMR-autism link, the difference in MMR usage by mother’s education level persisted and became more pronounced in 2003, 2004 and 2006, possibly as previous negative information received more weight than positive information in the parental decision-making process on whether or not to vaccinate.

She also found that the controversy, begun with the publication of research (later discredited) linking the MMR vaccine to risks for autism in “The Lancet” medical journal, seemingly had a spillover effect to other vaccines—such as polio or other measles-containing vaccines—likely as a result of concern for safety over the MMR controversy.
 
Chang says the decline is a significant decrease and attributes the spillover effect to parental concerns.
 
“The I find on other vaccines such as polio and, to a lesser degree DTP (diphtheria, tetanus and pertussis), could be partially ascribed to general safety concerns toward all vaccines that stemmed from the MMR controversy, but other factors might be at play as well,” Chang says.
 
In other related work, Chang is researching the effect on immunization rates of state mandates that require insurance companies to cover childhood vaccines.  

Related Stories

Vaccines and autism: Many hypotheses, but no correlation

Jan 30, 2009

An extensive new review summarizes the many studies refuting the claim of a link between vaccines and autism. The review, in the February 15, 2009 issue of Clinical Infectious Diseases and now available online, looks at the ...

Does the H1N1 vaccine contain mercury?

Sep 15, 2009

In the words of President Obama "don't be alarmed, be prepared" for the swine flu (or, officially, the H1N1 virus). But what if the preparation is more alarming than the flu?

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.